STAT+: Two FDA approvals — a new drug and a new vaccine

Takeda's narcolepsy drug approved, the first mRNA flu shot approved, and more biotech updates from The Readout

U.S. moves to shut a Kentucky organ donation group, citing safety failures

The U.S. moves to shut a Kentucky organ donation group that's been accused of continuing plans for organ retrieval from some patients who unexpectedly showed signs of life.

How Africa can power its trillion-dollar critical minerals revolution

Commerce Department proposes tariffs on more steel, aluminum, copper goods

The agency wants to impose duties on derivative products ranging from brass wind instruments and floor safes to tanker trailers and semi-trailers.

Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid response

“A transparent evaluation of Covid would separate what happened from competing political narratives and help us improve for the future,” writes IDSA President Ronald Nahass.

Retailers — eager for cash — sell off rights to potential tariff refunds

A secondary market has emerged for retailers, such as American Eagle Outfitters and The Children's Place, to get capital quicker by monetizing tariff refunds.

10 Quotes from Mountains to Cross by Abraham M. George

Discover 5 inspiring lessons from Mountains to Cross by Abraham M. George on purpose, service, resilience, education, and impact.

Senate committee votes along party lines to hold Fauci in contempt of Congress

A Senate committee has voted to hold Anthony Fauci in contempt of Congress after he declined to answer questions about his role in the Covid pandemic.

Plantible raises $35m in debt, equity, to increase RuBisCO protein production fivefold

“We have rolled out a new [lemna] strain that has allowed us to increase our yield by more than 40%, which has been pretty exciting,” says CEO Tony Martens. The post Plantible raises $35m in debt, equity, to increase RuBisCO protein production fivefold appeared first on AgFunderNews.

Major study challenges long-held fears about acetaminophen and ibuprofen use in babies

A landmark study of nearly 4,000 babies found that acetaminophen and ibuprofen were equally safe during infancy. Neither medicine was linked to eczema or bronchiolitis, and no serious side effects were caused by the drugs. Researchers will continue following the children through age six to study possible long-term effects.